No connection

Search Results

Corporate Score 25 Neutral

Artisan Mid Cap Value Fund Exits Bio-Rad Laboratories Holding in Q4

Apr 01, 2026 15:00 UTC
BIO
Short term

The Artisan Mid Cap Value Fund has sold its stake in Bio-Rad Laboratories (BIO) during the fourth quarter. The move reflects a strategic shift in the fund's portfolio.

  • Artisan Mid Cap Value Fund sold Bio-Rad Laboratories (BIO) in Q4 2025.
  • The sale is part of the fund's portfolio rebalancing strategy.
  • Bio-Rad operates in the healthcare sector, focusing on life science research and clinical diagnostics.
  • The move is unlikely to cause major market disruptions.
  • Investors may watch for further changes in the fund's holdings.

The Artisan Mid Cap Value Fund has divested its position in Bio-Rad Laboratories (BIO) in the fourth quarter of 2025. This decision aligns with the fund's ongoing strategy to rebalance its portfolio. Bio-Rad Laboratories, a healthcare sector company, is a provider of life science research and clinical diagnostic products. While the sale may impact Bio-Rad's investor base, it is not expected to significantly affect the broader market. The fund's decision could signal a reassessment of its exposure to the healthcare sector or a reallocation of resources to other opportunities. Investors should monitor any further changes in the fund's holdings for potential insights into market trends.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Share this article

Related Articles

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI
Markets
Profile